Skip to main content
رجوع
Watch Compare

Fuse Medical, Inc.

جودة البيانات: 100%
FZMD
OTC Wholesale Trade Durable Goods Wholesale
KWD 0.02
KWD 0.00 (0.00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-8.28%

النمو

Revenue Growth (5Y)
-8.28%
أقل من متوسط القطاع (2.60%)
Revenue (1Y)-8.67%
Earnings (1Y)N/A
FCF Growth (3Y)-59.85%

الجودة

Return on Equity
N/A
ROIC-3.30%
Net Margin19.72%
Op. Margin-1.30%

الأمان

Debt / Equity
N/A
Current Ratio1.06
Interest Coverage-1.13

التقييم

PE (TTM)
0.41
أعلى من متوسط القطاع (-0.16)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Revenue declined -8.28% annually over 5 years
Net margin of 19.72% shows strong profitability
Generating 18,641.0 in free cash flow
P/E of 0.41 — trading at a low valuation

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

Growth

Rev 5Y: -8.28% · Earnings 1Y: N/A
Revenue Growth (1Y) -8.67% Revenue Growth (3Y) -6.66%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -8.28% Earnings Growth (5Y) -5.94%

Profitability

ROE: N/A · Net Margin: 19.72%
Revenue (TTM) 18.40 M Net Income (TTM) 3.63 M
ROE N/A ROA 19.23%
Gross Margin 64.95% Operating Margin -1.30%
Net Margin 19.72% Free Cash Flow (TTM) 18,641.0
ROIC -3.30% FCF Growth (3Y) -59.85%

Safety

D/E: N/A · Current: 1.06
Debt / Equity N/A Current Ratio 1.06
Interest Coverage -1.13 Asset Turnover 0.98
Working Capital 754,339 Tangible Book Value -3.33 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs

Valuation

P/E: 0.41 · EV/EBITDA: N/A
P/E Ratio 0.41 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.08
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 1.26%
Market Cap 1.48 M Enterprise Value 1.22 M

Per Share

EPS: 0.04 · FCF/Share: 0.00
EPS (Diluted TTM) 0.04 Revenue / Share 0.25
FCF / Share 0.00 OCF / Share -0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) -9.64%
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 0.51% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 0.51%
SBC-Adj. FCF 1,649 Growth Momentum -0.39

Income Statement

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Revenue 18.64 M 20.41 M 21.40 M 22.90 M 26.34 M
Net Income 3.10 M -1.59 M -1.43 M -3.32 M 3.96 M
EPS (Diluted) 0.04 -0.02 -0.02 -0.05 0.06
Gross Profit 11.54 M 11.94 M 12.70 M 11.14 M 12.99 M
Operating Income -815,072.0 -2.20 M -1.03 M -4.35 M -1.96 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses 6.54 M 7.01 M 6.54 M 8.47 M 8.47 M
D&A 137,403.0 67,638.0 104,143.0 107,073.0 49,685.0
Interest Expense 171,294.0 78,230.0 94,953.0 121,633.0 133,944.0
Income Tax 23,655.0 17,723.0 18,993.0 781,085.0 -386,784.0

Balance Sheet

Annual, most recent first
Metric FY2022 FY2021 FY2020 FY2019 FY2018
Total Assets 19.76 M 18.30 M 17.42 M 18.38 M 22.17 M
Total Liabilities 20.07 M 21.74 M 19.53 M 19.60 M 20.71 M
Shareholders' Equity -310,854.0 -3.43 M -2.11 M -1.22 M 1.47 M
Total Debt — — — — —
Cash & Equivalents 147,854.0 553,190.0 1.19 M 1.10 M 844,314.0
Current Assets 13.77 M 12.82 M 12.62 M 15.17 M 17.18 M
Current Liabilities 12.39 M 9.94 M 7.25 M 7.96 M 7.12 M

مقارنة الأقران

مقابل وسيط قطاع Wholesale Trade (100 نظير)
المقياس السهم وسيط القطاع
P/E 0.4 -0.2
P/B — 1.0
ROE % — -4.2
Net Margin % 19.7 -2.4
Rev Growth 5Y % -8.3 2.6
D/E — 0.3

تاريخ التوزيعات

المدفوعات الأخيرة لكل سهم (الأحدث أولاً).

تاريخ الاستحقاق الدفع المبلغ / سهم
Oct 22, 2010 — KWD 7.35